NCT05508464View on ClinicalTrials.gov

Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial

NARecruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

October 16, 2023

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2027

Conditions
Metastatic Cancer
Interventions
RADIATION

Arm 2: SABR

SABR to all tumors 6 Gy x 5 over three weeks

RADIATION

Arm 1: Standard of Care

Standard of care palliative radiotherapy

Trial Locations (1)

N6A 5W9

RECRUITING

London Health Sciences Centre- London Regional Cancer Program, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER